Evidence map›Paper›PMID 29921155›Full record

ReviewNutrition and health2018

Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).

Tobias Banaschewski, Brendan Belsham, Michael H Bloch, Maite Ferrin, Mats Johnson, James Kustow, Sarah Robinson, Alessandro Zuddas

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nutrition and health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 5 countries.

Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany.
Brendan BelshamPrivate practice, Johannesburg, South Africa.
Michael H BlochChild Study Center and Department of Psychiatry, Yale University, New Haven, USA.
Maite FerrinRe:Cognition Health, London, UK.
Mats JohnsonGillberg Neuropsychiatry Centre, Sahlgrenska Academy, Göteborg University, Sweden.
James KustowConsultant Adult Psychiatrist and Adult ADHD specialist, London, UK.
Sarah RobinsonPCM Scientific, London, UK.ORCID http://orcid.org/0000-0002-8232-0037
Alessandro ZuddasChild and Adolescent Neuropsychiatry Unit, Department of Biomedical Science, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Italy.
Cambridge Cognition (United Kingdom) · GBConstruction Industry Training Board · GBHeidelberg University · DEUniversity of Cagliari · ITUniversity of Gothenburg · SEYale University · US

Funding

Research Training for Medical Students & Physician-Scientists in Child PsychiatryR25MH077823 · NIMH · YALE UNIVERSITY · PI ANDRES S MARTIN · 2006 to 2026
$4.0M
NIMH NIH HHS R25 MH077823
6 · The paper itself

Abstract

While pharmacotherapy and psychosocial interventions are recommended as the primary frontline treatment for attention deficit hyperactivity disorder (ADHD), alternative approaches to managing ADHD are becoming increasingly popular among patients and their families. Supplementation with polyunsaturated fatty acids (PUFAs) is an example of this. PUFA supplementation is not recommended by guidelines for managing ADHD; however, patients may still decide to use it. To provide direction to healthcare professionals (HCPs) managing ADHD, eight international experts in the field of adult and child ADHD came together for the Continuum Education Board: Omega Supplements in ADHD meeting. This commentary summarises the panel's consensus that current evidence suggests PUFA supplementation has a small beneficial effect on behaviour in children with ADHD, and that further high-quality research is needed to clearly evaluate and define its role in the management of ADHD of children, adolescents and adults. The panel concluded that in cases where patients use PUFA supplementation, HCPs should be comfortable explaining the potential gains that they may have and their possible side effects. The panel also concluded HCPs should not reinforce the idea that PUFA supplementation should replace treatment approaches with a more robust evidence base for managing ADHD.

Indexed as

Dietary SupplementsAdolescentAdultAttention Deficit Disorder with HyperactivityChildFatty Acids, UnsaturatedHumansFatty Acids, UnsaturatedADHDattention deficit hyperactivity disorderhealthNutritionomegapolyunsaturated fatty acidsPUFAsupplements

Identifiers

PMID29921155
PMCPMC6291899
OpenAlexW2809434709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.